Investor Relations

2025/04/25

IR

Consolidated Financial Results for the Fiscal Year Ended March 31, 2025

2025/04/25

IR

Notice Concerning Dividens of Surplus

2025/04/25

IR

Notice Concerning Change of Representative Director

2025/04/25

IR

Notice Concerning Partial Amendments to the Articles of Incorporation

2025/01/31

IR

Third Quarter Financial Results for FY2024

2025/01/31

IR

Consolidated Financial Results for the Nine Months Ended December 31, 2024